HomeFileCoronary disease

Coronary disease

View Category

Acute coronary syndromes

Cangrelor: Additional Research Findings Not Translating into Clinical Practice

The potent and fast endovenous platelet inhibition provided by Cangrelor reduces ischemic events early in the course...
solaci -
Learn More
CHIP LATAM News

Watch again the launch of the new department of SOLACI, CHIP LATAM on our Youtube account

Watch again "the launch of the new department of SOLACI, CHIP LATAM" on our Youtube account. Check it...
solaci -
Learn More
Antiplatelet

Clnical Practice Dissociated from Study Outcomes: Bad News for Our Patients?

Differences in patient characteristics, changes in treatment algorithms, and advances in device technology, together or separately, might...
solaci -
Learn More
Acute coronary syndromes

TICO: Age Impacts the Effect of Antiplatelet Monotherapy

The higher the age, the greater the benefit of ticagrelor monotherapy vs. dual antiplatelet therapy (DAPT) in...
solaci -
Learn More
Antiplatelet

Post-PCI Ticagrelor Monotherapy in High-Risk Bleeding

In patients at high risk of bleeding undergoing coronary PCI and after completing 3-month DAPT with no...
solaci -
Learn More
Coronary disease

The Most Relevant of 2021 In Coronary Disease

This last year, new data in coronary disease gave way to changes in practices and new hypotheses,...
solaci -
Learn More
Chronic Ischemic cardiopathy

Women Present Lower Risk of Sport Related Sudden Death Compared to Men

According to this recent analysis published in Eur Heart J, women would have a far lower chances...
solaci -
Learn More
Chronic Ischemic cardiopathy

The FDA Approves Intravascular Lithotripsy for Calcified Lesions

The US Food and Drug Administration (FDA) has cleared the shockwave lithotripsy system to treat severely calcified...
solaci -
Learn More